SIRPA and neoplasm: CD47-SIRPα axis serves as “don't eat me” signal to the innate immune response 7, 8, whereas SIRPα-CD47 checkpoint blockade promotes phagocytosis by phagocytes such as macrophages and DCs leading to tumor regression by activation of innate immune response 23, 37, 38.